34.74
-1.93
(-5.26%)
At close: January 13 at 4:00:01 PM EST
35.89
+1.15
+(3.31%)
Pre-Market: 6:23:41 AM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUSTIN STEPHEN G Director | Conversion of Exercise of derivative security | Mar 16, 2020 | 91,987 |
| BAUM MARK L Chief Executive Officer | Purchase | Mar 22, 2024 | 2,137,520 |
| BOLL ANDREW R Chief Financial Officer | Conversion of Exercise of derivative security | Feb 20, 2024 | 568,089 |
| KAMMER ROBERT J Director | Sale | Nov 11, 2019 | 797,327 |
| LINDSTROM RICHARD L Director | Sale | Sep 30, 2022 | -- |
| MAKARY MARTIN A. Director | Purchase | Aug 14, 2023 | 45,000 |
| OPALEYE MANAGEMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 25, 2024 | -- |
| PRINCIPI ANTHONY J Director | Conversion of Exercise of derivative security | Sep 28, 2020 | 93,798 |
| SAHAREK JOHN P Officer | Conversion of Exercise of derivative security | Sep 11, 2024 | 299,663 |
| VAN HORN R LAWRENCE Director | Purchase | Dec 22, 2022 | 1,860 |
Related Tickers
ETON Eton Pharmaceuticals, Inc.
14.00
+4.17%
CPHRF Cipher Pharmaceuticals Inc.
9.84
+0.51%
LNTH Lantheus Holdings, Inc.
94.65
-1.28%
SBBC.V Simply Better Brands Corp.
1.1200
+3.70%
PHO.OL Photocure ASA
56.50
-0.35%
KNSA Kiniksa Pharmaceuticals International, plc
18.17
-8.83%
IRWD Ironwood Pharmaceuticals, Inc.
3.7700
-4.80%
AVDL Avadel Pharmaceuticals plc
7.82
-1.01%
AMRX Amneal Pharmaceuticals, Inc.
7.72
-3.14%
NBIX Neurocrine Biosciences, Inc.
143.03
+1.51%